BMS aims for US approval of Opdivo combo in stomach cancer

If Opdivo wins an approval for first-line gastric cancer, it could gain an advantage over Merck &Co’s (MSD) rival checkpoint inhibitor Keytruda (pembrolizumab).

Trial failure for bintrafusp alfa casts doubt on GSK/Merck KGaA’s cancer alliance

In a statement, Merck said that the study’s Independent Data Monitoring Committee (IDMC) recommended that the trial should be discontinued, as it is ‘unlikely’ to meet the co-primary endpoint ... program,” said Danny Bar-Zohar, global head of

Lateral flow tests detect ‘most infectious’ COVID-19 cases, Oxford researchers find

commented David Eyre, co-leader of the study and associate professor at Oxford’s Big Data Institute and Nuffield Department of Population Health.

Sourcing R&D innovation: why pharma companies need to evolve their business models

Similarly, Novartis formed the investment firm Novartis Venture Funds and Merck &Co. ... created the Merck Research Venture Fund. Nowadays, having a venture arm to proactively research for outside R&D sourcing is common for most mid- to large- sized

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]